Topics
Glioblastoma | Treatment | Off-label Medications | Posaconazole
Home > Publications > Topics > Glioblastoma > Treatment > Off-label Medications > Posaconazole
Mansouri A, de Macedo Filho L, Tufano E, Laukhuff H, Zacharia B,
Neighbors J, Green M, Derosia N, Sun D, Bhanja D, Tuohy K, Connor
J, Aregawi DG, Glantz M, Zadeh G.
A
phase 0 clinical trial to evaluate the neuropharmacological
profile of posaconazole for glioblastoma.
Neurooncol
Adv. 2026 Jul 2;8(1):vdag174. doi:
10.1093/noajnl/vdag174. PMID:
42494994. Trial
registration ID: NCT04825275. ˍ